ArticleScientific reports2022

Co-administration of Lactobacillus gasseri KBL697 and tumor necrosis factor-alpha inhibitor infliximab improves colitis in mice.

Dae Hee Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.